bruker.com - BRKR Total Company Value-to-Revenue Ratio

Bruker Corp (BRKR) - corporate logo

Bruker Corporation (BRKR) is capturing the complex analytics market through mergers with microscope developers, creating a closed ecosystem for pharma behemoths. Technological leadership in NMR and mass spectrometry makes the company a key link in the biotech industry. This chart of the company's enterprise value-to-revenue ratio demonstrates fundamental stability, with the metric holding at 2910.96. Geopolitical risks remain minimal due to the humanitarian status of science and stability within the US and EU.

Bruker Corp. (BRKR) EV/Sales Multiple: for the period 11/23/2025 - 11/21/2026

Financial and market metric breakdowns for Bruker Corp. (BRKR)

- share price and consensus valuation forecast:
Fundamental company valuation:BRKR, bruker.com
Flagship merchandise of Bruker Corp

To find fundamental support for Bruker Corporation (BRKR), it is essential to evaluate the value of its high-tech production of mass spectrometers and diagnostic systems relative to generated revenue. By analyzing the business valuation via EV/Sales, an investor views the market capitalization adjusted for net debt, which determines whether the current price is a fair reflection of the company's scale or a sign that the asset is overbought.